Adverse Event Analysis
Root cause analysis of adverse events and identification of risk factors for adverse events are performed. The likelihood of future adverse events is predicted, patients at high risk for adverse events are identified, and resources and interventions are targeted to areas where they are most needed.
Pharma Business Analysis
Pharmaceutical business analysis services include market research and competitive intelligence, and pharmacoeconomics and health outcomes. Data visualization and data analysis are used to evaluate and compare different drugs and their market and health impacts.
PK/PD Data Analysis
Pharmaceutical business analysis services include market research and competitive intelligence, and pharmacoeconomics and health outcomes. Data visualization and data analysis are used to evaluate and compare different drugs and their market and health impacts.
SERVICES
We offer a variety of services in three domains of data analysis for the pharmaceutical industry:
- PK/PD data analysis, pharmaceutical business analysis, and adverse event analysis.
- We use state-of-the-art tools and methods to handle, model, simulate, and visualize your data, and to generate comprehensive and informative reports.
- We also collaborate with you to understand your needs, objectives, and expectations, and to deliver customized and high-quality services
Pharmacokinetic / Pharmacodynamic data Analysis
Data Management & Quality Control
We use data visualization to organize, clean, and check the quality and consistency of the PK/PD data collected from various sources and formats.
Model development and validation
We use data analysis to develop and validate mathematical models that describe the relationship between the dose, concentration, and effect of a drug, and to estimate the model parameters and their uncertainty.
Model-based simulation and optimization
We use data analysis to simulate and optimize the PK/PD behavior and response of a drug under different scenarios and conditions, and to support the design and decision making of drug development and clinical trials.
Population and individual analysis
We use data analysis to account for the variability and covariates of the PK/PD data across and within different populations and individuals, and to provide personalized dosing and treatment recommendations.
Data integration and visualization
We use data visualization to integrate and visualize the PK/PD data and models from multiple sources and levels, and to communicate and present the results and insights to various stakeholders.
Adverse Event data Analysis
Descriptive Reports
We provide summary of adverse events by product, route of administration, and other factors, frequency of adverse events by age, sex, and other demographic factors, severity of adverse events, time to onset of adverse events, and outcomes of adverse events
Diagnostic Reports
We perform root cause analysis of adverse events and identification of risk factors for adverse events.
Predictive Reports
We predict the likelihood of future adverse events, identify patients at high risk for adverse events, and target resources and interventions to areas where they are most needed.
Risk Assessment Reports
We assess the risks associated with different products, services, or procedures, compare the risks of different products, services, or procedures, and communicate the risks to patients and other stakeholders.
Pharma Business Analysis
Market Research & Competitive Intelligence
We use data visualization to explore and compare the market size, share, trends, opportunities, and threats of different drugs, indications, regions, and competitors.
Pharmacoeconomics & health outcomes
We use data analysis to assess the cost-effectiveness, cost-benefit, and risk-benefit of different drugs, and to measure their impact on the health and quality of life of patients.
